Abstract: An electronic camera assembly includes a camera chip cube bonded to camera bondpads of an interposer; at least one light-emitting diode (LED) bonded to LED bondpads of the interposer at the same height as the camera bondpads; and a housing extending from the interposer and LEDs to the height of the camera chip cube, with light guides extending from the LEDs through the housing to a top of the housing. In embodiments, the electronic camera assembly includes a cable coupled to the interposer. In typical embodiments the camera chip cube has footprint dimensions of less than three and a half millimeters square.

Abstract: A semiconductor device, including a substrate, a first source/drain region, a second source/drain region, and a gate structure, is provided. The substrate has an extra body portion and a fin protruding from a top surface of the substrate, wherein the fin spans the extra body portion. The first source/drain region and the second source/drain region are in the fin. The gate structure spans the fin, is located above the extra body portion, and is located between the first source/drain region and the second source/drain region.

Abstract: A pneumatic hydraulic retractable device includes a fluid pressure cylinder having a cylinder body and a plug seat disposed in the cylinder body, a piston rod movably disposed in the fluid pressure cylinder, a control valve set having a valve seat disposed at the piston rod and forms an upper fluid chamber and a lower fluid chamber with the cylinder body therebetween, and a valve rod disposed in the valve seat for controlling communication between the upper and lower fluid chambers, and a pressure relief element forming a pressure relief gap with the piston rod. The pressure relief gap communicates with the lower fluid chamber through a communication portion of the pressure relief element. As such, when the valve rod is opened, the fluid is allowed to flow between the lower fluid chamber and the pressure relief gap through the communication portion for reducing airtight effect.

Abstract: The present disclosure provides a compound of Formula (I) a pharmaceutically acceptable salt or a stereoisomer and their use in, e.g. treating a condition, disease or disorder in which the inhibition of the interaction of SOS 1 and a RAS-family protein or RAC1 is of therapeutic benefit, specifically in treating oncological diseases. This disclosure also features compositions containing the same as well as methods of using and making the same.

Abstract: In at least one example, an apparatus includes a current sense circuit, an imbalance detector, and a current balancer. The current sense circuit including a first phase input, a second phase input, a first sense output, and a second sense output. The imbalance detector having a detector output, a first detector input, and second detector input. The first detector input is coupled to the first sense output and the second detector input is coupled to the second sense output. The current balancer having a balancer input and a balancer output. The balancer input is coupled to the detector output.

Abstract: A DC-DC converter includes a ramp generator, a threshold voltage circuit, and a control circuit. The ramp generator is configured to generate a voltage ramp. The threshold voltage circuit is configured to generate a threshold voltage. The control circuit is coupled to the ramp generator and the threshold voltage circuit. The control circuit includes a digital pulse width modulator (DPWM) circuit and a loop compensation circuit coupled to the DPWM circuit. The DPWM circuit is configured to generate a power stage switch control signal responsive to a loop compensation value. The loop compensation circuit is coupled to the DPWM circuit. The loop compensation circuit is configured to calculate the loop compensation value responsive to the voltage ramp exceeding the threshold voltage.

Abstract: A mobile device includes a connector, an audio generator, a biological signal processor, a switch element, and a controller. The switch element has a first terminal and a second terminal. The first terminal of the switch element is coupled to the connector, and the second terminal of the switch element is selectively coupled to either the audio generator or the biological signal processor according to a control signal. The controller is coupled to the audio generator and the biological signal processor, and is configured to generate the control signal.

Abstract: An example apparatus includes: a first and second capacitor; a first and second inductor; a first switch having a first and second terminal, the first terminal coupled to the first capacitor, and the second terminal coupled to the first and second inductor; a second switch having a third and fourth terminal, the third terminal coupled to the second terminal, the fourth terminal coupled to the second capacitor; a third switch having a fifth and sixth terminal, the fifth terminal coupled to the first terminal, the sixth terminal coupled to the second inductor; and a diode having a seventh and eighth terminal, the seventh terminal coupled to the sixth terminal, the eighth terminal coupled to the fourth terminal.

Abstract: A one-time programmable nonvolatile memory cell includes a substrate providing a first conductivity type well and a second conductivity type well, a first MOS transistor having a floating gate and a gate oxide, and an auxiliary gate and a gate oxide formed by extending one end of the floating gate and the gate oxide of the first MOS transistor from an edge of the first active region, along a second direction perpendicular to the first direction, passing through the isolation region until to cover a part or an entire of the second active region. The first and the second active regions are separated by an isolation region, and the first and second active regions and the isolation region are arranged parallel to each other along a first direction. The memory cell has an improved structure and optimized performance and a reduced size.

Abstract: A use that relates to mannuronic acid oligosaccharides or a composition comprising same in the treatment of Th1-dominance related diseases. The Th1-dominance related diseases may be selected from Multiple Sclerosis, Crohn's disease, Type I Diabetes, Rheumatoid Arthritis, Hashimoto's thyroiditis, vitiligo, Sjögren's Syndrome, Polycystic ovary syndrome, Celiac Disease and Grave's disease, preferably from Multiple Sclerosis, Crohn's disease and Rheumatoid Arthritis.

Abstract: Provided is a use of an agent for regulating an amino acid level in preparing a drug for treating Alzheimer's disease in a subject.

Abstract: The present invention relates to identification of a carbohydrate drug-sensitive patient in patients having Alzheimer's disease. The present invention provides a method for identifying a carbohydrate drug-sensitive patient in patients having Alzheimer's disease.

Abstract: The present invention relates to the treatment of Alzheimer's disease. Provided is the use of an reagent for regulating the relative abundance of intestinal microorganisms in the preparation of a medicament for treating Alzheimer's disease in a subjet.

Abstract: Provided is the use of a reagent for inhibiting the uptake of amino acids by naive T cells in the preparation of a drug for treating Alzheimer's disease in a subject.

Abstract: A vehicle engagement structure for towing transport devices is disclosed, wherein a carrier is configured with respectively an engagement towage mechanism and a drive mechanism; more specifically, the engagement towage mechanism includes an external spiral transmission component and an internal spiral transmission component, the internal spiral transmission component is further mutually in spiral engagement with a spiral rod, and the top end of the spiral rod is sequentially installed with an up-and-down pedestal, a rotation seat, an engagement base and an engagement end applied to connect to a transport device; in addition, the drive mechanism is configured to control the up-and-down pedestal to vertically ascend or descend on the spiral rod, thereby facilitating the engagement end to adapt to the height of the transport device or topographic fluctuations and variations during movement.

Abstract: A towing vehicle for transport devices includes a body, a connection mechanism, a transmission mechanism and a drive mechanism, wherein the front and rear ends of the body are respectively and pivotally installed with track wheels, and each of the track wheels is provided with a second passive gear; the connection mechanism is installed on the body for connecting the towed transport device; the transmission mechanism is installed on both sides of the body, and each of the transmission mechanisms has a primary transmission shaft and two secondary transmission shafts, in which the primary transmission shaft has a first active gear, and the secondary transmission shaft has a second active gear and a first passive gear; moreover, the drive mechanism is used to drive each primary transmission shaft to operate.

Abstract: A vehicle engagement structure for towing transport devices is disclosed, wherein a carrier is configured with respectively an engagement towage mechanism and a drive mechanism; more specifically, the engagement towage mechanism includes an external spiral transmission component and an internal spiral transmission component, the internal spiral transmission component is further mutually in spiral engagement with a spiral rod, and the top end of the spiral rod is sequentially installed with an up-and-down pedestal, a rotation seat, an engagement base and an engagement end applied to connect to a transport device; in addition, the drive mechanism is configured to control the up-and-down pedestal to vertically ascend or descend on the spiral rod, thereby facilitating the engagement end to adapt to the height of the transport device or topographic fluctuations and variations during movement.

Abstract: A geometric camera calibration system includes an extrinsic iterative closest point (ICP) device that generates an estimated extrinsic matrix by adjusting an initial extrinsic matrix according to first 3D points in camera coordinates; and an intrinsic ICP device that receives 3D points in chessboard coordinates and accordingly generates an error metric between the 3D points in chessboard coordinates and predetermined second reference 3D points. The extrinsic ICP device performs ICP operation to minimize difference between the 3D points in camera coordinates and predetermined first reference 3D points. A current intrinsic matrix is then outputted as an updated intrinsic matrix if a current error metric is not greater than a previous error metric.

Abstract: A compound of general formula I: is disclosed. The compound be used to prevent or treat hepatitis B virus infection.

Abstract: A compound of general formula I: is disclosed. The compound be used to prevent or treat hepatitis B virus infection.